ID

36070

Description

HAIC Using Oxaliplatin Plus Fluorouracil/Leucovorin for Patients With Locally Advanced HCC; ODM derived from: https://clinicaltrials.gov/show/NCT02436044

Link

https://clinicaltrials.gov/show/NCT02436044

Keywords

  1. 4/13/19 4/13/19 -
  2. 9/20/21 9/20/21 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

April 13, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Hepatocellular Carcinoma NCT02436044

Eligibility Hepatocellular Carcinoma NCT02436044

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
no extrahepatic spread on imaging, and filfill one of them as follows: 1.multiple hcc lesions,> 5.0 cm in diameter;2.portal venous hepatic vein/tumor thrombus or arteriovenous/portal fistula;3.direct invasion adjacent organs except gallbladder or penetrate the peritoneum;4.diffuse hcc.
Description

Neoplasm Metastasis Extrahepatic Absent Imaging | Liver carcinoma Multiple lesions | Lesion Diameter | Portal vein Tumor thrombus | Hepatic vein Tumor thrombus | Arteriovenous fistula | Tumor Cell Invasion Organs Adjacent | Exception Gallbladder | Liver carcinoma Diffuse

Data type

boolean

Alias
UMLS CUI [1,1]
C0027627
UMLS CUI [1,2]
C1517058
UMLS CUI [1,3]
C0332197
UMLS CUI [1,4]
C0011923
UMLS CUI [2,1]
C2239176
UMLS CUI [2,2]
C0577305
UMLS CUI [3,1]
C0221198
UMLS CUI [3,2]
C1301886
UMLS CUI [4,1]
C1305775
UMLS CUI [4,2]
C3163918
UMLS CUI [5,1]
C0019155
UMLS CUI [5,2]
C3163918
UMLS CUI [6]
C0003855
UMLS CUI [7,1]
C1269955
UMLS CUI [7,2]
C0178784
UMLS CUI [7,3]
C0205117
UMLS CUI [8,1]
C1705847
UMLS CUI [8,2]
C0016976
UMLS CUI [9,1]
C2239176
UMLS CUI [9,2]
C0205219
eastern cooperative oncology group performance status 0-2
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
child-pugh stage a or b
Description

Child-Pugh Classification

Data type

boolean

Alias
UMLS CUI [1]
C2347612
at least one evaluable intrahepatic target lesions
Description

Target Lesion intrahepatic Evaluable Quantity

Data type

boolean

Alias
UMLS CUI [1,1]
C2986546
UMLS CUI [1,2]
C1512948
UMLS CUI [1,3]
C1516986
UMLS CUI [1,4]
C1265611
previous accept sorafenib but stoped for more than 4 weeks because of disease progression or intolerance to sorafenib or refused to recieved sorafenib
Description

Sorafenib | Sorafenib Discontinued | Disease Progression | Intolerance to Sorafenib | Sorafenib Refused

Data type

boolean

Alias
UMLS CUI [1]
C1516119
UMLS CUI [2,1]
C1516119
UMLS CUI [2,2]
C1444662
UMLS CUI [3]
C0242656
UMLS CUI [4,1]
C1744706
UMLS CUI [4,2]
C1516119
UMLS CUI [5,1]
C1516119
UMLS CUI [5,2]
C1705116
stoped for more than 4 weeks after local treatments(surgical resection, radiofrequency ablation, transcatheter arterial chemoembolization) of tumor if presence
Description

Local Therapy Tumor | Excision | Radiofrequency ablation | Transarterial Chemoembolization

Data type

boolean

Alias
UMLS CUI [1,1]
C1517925
UMLS CUI [1,2]
C0027651
UMLS CUI [2]
C0728940
UMLS CUI [3]
C0850292
UMLS CUI [4]
C3539919
sign the informed consent.
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
ever received oxaliplatin or fluorouracil/leucovorin;
Description

oxaliplatin | Fluorouracil | Leucovorin

Data type

boolean

Alias
UMLS CUI [1]
C0069717
UMLS CUI [2]
C0016360
UMLS CUI [3]
C0023413
a platelet counts of > 60,000/mm3, prothrombin time activity <40%;
Description

Platelet Count measurement | Prothrombin time assay

Data type

boolean

Alias
UMLS CUI [1]
C0032181
UMLS CUI [2]
C0033707
albumin <2.8 g/dl, total bilirubin ≥51.3 umol/l; alanine aminotransferase (alt) and aspartate transaminase(ast)≥5 times of upper limit
Description

Albumin measurement | Serum total bilirubin measurement | Alanine aminotransferase increased | Aspartate aminotransferase increased

Data type

boolean

Alias
UMLS CUI [1]
C0201838
UMLS CUI [2]
C1278039
UMLS CUI [3]
C0151905
UMLS CUI [4]
C0151904
uncontrolled or refractory ascites, ongoing variceal bleeding or encephalopathy;
Description

Ascites Uncontrolled | Refractory Ascites | Bleeding varices | Encephalopathy

Data type

boolean

Alias
UMLS CUI [1,1]
C0003962
UMLS CUI [1,2]
C0205318
UMLS CUI [2,1]
C0205269
UMLS CUI [2,2]
C0003962
UMLS CUI [3]
C0333106
UMLS CUI [4]
C0085584
severe heart, brain or kidney diseases
Description

Heart Diseases Severe | Brain Diseases Severe | Kidney Diseases Severe

Data type

boolean

Alias
UMLS CUI [1,1]
C0018799
UMLS CUI [1,2]
C0205082
UMLS CUI [2,1]
C0006111
UMLS CUI [2,2]
C0205082
UMLS CUI [3,1]
C0022658
UMLS CUI [3,2]
C0205082
previous or concurrent cancer that is distinct in primary site or histology from hcc
Description

Cancer Other | Primary tumor site Different Liver carcinoma | Histology Different Liver carcinoma

Data type

boolean

Alias
UMLS CUI [1]
C1707251
UMLS CUI [2,1]
C0475447
UMLS CUI [2,2]
C1705242
UMLS CUI [2,3]
C2239176
UMLS CUI [3,1]
C4048239
UMLS CUI [3,2]
C1705242
UMLS CUI [3,3]
C2239176
pregnant women or lactating women;
Description

Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
allergy to fluorouracil, oxaliplatin, leucovorin calcium or iodine contrast agent.
Description

Fluorouracil allergy | Hypersensitivity Oxaliplatin | Hypersensitivity Leucovorin Calcium | Iodine contrast allergy

Data type

boolean

Alias
UMLS CUI [1]
C0570698
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0069717
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0731033
UMLS CUI [4]
C4022917

Similar models

Eligibility Hepatocellular Carcinoma NCT02436044

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Neoplasm Metastasis Extrahepatic Absent Imaging | Liver carcinoma Multiple lesions | Lesion Diameter | Portal vein Tumor thrombus | Hepatic vein Tumor thrombus | Arteriovenous fistula | Tumor Cell Invasion Organs Adjacent | Exception Gallbladder | Liver carcinoma Diffuse
Item
no extrahepatic spread on imaging, and filfill one of them as follows: 1.multiple hcc lesions,> 5.0 cm in diameter;2.portal venous hepatic vein/tumor thrombus or arteriovenous/portal fistula;3.direct invasion adjacent organs except gallbladder or penetrate the peritoneum;4.diffuse hcc.
boolean
C0027627 (UMLS CUI [1,1])
C1517058 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
C0011923 (UMLS CUI [1,4])
C2239176 (UMLS CUI [2,1])
C0577305 (UMLS CUI [2,2])
C0221198 (UMLS CUI [3,1])
C1301886 (UMLS CUI [3,2])
C1305775 (UMLS CUI [4,1])
C3163918 (UMLS CUI [4,2])
C0019155 (UMLS CUI [5,1])
C3163918 (UMLS CUI [5,2])
C0003855 (UMLS CUI [6])
C1269955 (UMLS CUI [7,1])
C0178784 (UMLS CUI [7,2])
C0205117 (UMLS CUI [7,3])
C1705847 (UMLS CUI [8,1])
C0016976 (UMLS CUI [8,2])
C2239176 (UMLS CUI [9,1])
C0205219 (UMLS CUI [9,2])
ECOG performance status
Item
eastern cooperative oncology group performance status 0-2
boolean
C1520224 (UMLS CUI [1])
Child-Pugh Classification
Item
child-pugh stage a or b
boolean
C2347612 (UMLS CUI [1])
Target Lesion intrahepatic Evaluable Quantity
Item
at least one evaluable intrahepatic target lesions
boolean
C2986546 (UMLS CUI [1,1])
C1512948 (UMLS CUI [1,2])
C1516986 (UMLS CUI [1,3])
C1265611 (UMLS CUI [1,4])
Sorafenib | Sorafenib Discontinued | Disease Progression | Intolerance to Sorafenib | Sorafenib Refused
Item
previous accept sorafenib but stoped for more than 4 weeks because of disease progression or intolerance to sorafenib or refused to recieved sorafenib
boolean
C1516119 (UMLS CUI [1])
C1516119 (UMLS CUI [2,1])
C1444662 (UMLS CUI [2,2])
C0242656 (UMLS CUI [3])
C1744706 (UMLS CUI [4,1])
C1516119 (UMLS CUI [4,2])
C1516119 (UMLS CUI [5,1])
C1705116 (UMLS CUI [5,2])
Local Therapy Tumor | Excision | Radiofrequency ablation | Transarterial Chemoembolization
Item
stoped for more than 4 weeks after local treatments(surgical resection, radiofrequency ablation, transcatheter arterial chemoembolization) of tumor if presence
boolean
C1517925 (UMLS CUI [1,1])
C0027651 (UMLS CUI [1,2])
C0728940 (UMLS CUI [2])
C0850292 (UMLS CUI [3])
C3539919 (UMLS CUI [4])
Informed Consent
Item
sign the informed consent.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
oxaliplatin | Fluorouracil | Leucovorin
Item
ever received oxaliplatin or fluorouracil/leucovorin;
boolean
C0069717 (UMLS CUI [1])
C0016360 (UMLS CUI [2])
C0023413 (UMLS CUI [3])
Platelet Count measurement | Prothrombin time assay
Item
a platelet counts of > 60,000/mm3, prothrombin time activity <40%;
boolean
C0032181 (UMLS CUI [1])
C0033707 (UMLS CUI [2])
Albumin measurement | Serum total bilirubin measurement | Alanine aminotransferase increased | Aspartate aminotransferase increased
Item
albumin <2.8 g/dl, total bilirubin ≥51.3 umol/l; alanine aminotransferase (alt) and aspartate transaminase(ast)≥5 times of upper limit
boolean
C0201838 (UMLS CUI [1])
C1278039 (UMLS CUI [2])
C0151905 (UMLS CUI [3])
C0151904 (UMLS CUI [4])
Ascites Uncontrolled | Refractory Ascites | Bleeding varices | Encephalopathy
Item
uncontrolled or refractory ascites, ongoing variceal bleeding or encephalopathy;
boolean
C0003962 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0205269 (UMLS CUI [2,1])
C0003962 (UMLS CUI [2,2])
C0333106 (UMLS CUI [3])
C0085584 (UMLS CUI [4])
Heart Diseases Severe | Brain Diseases Severe | Kidney Diseases Severe
Item
severe heart, brain or kidney diseases
boolean
C0018799 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0006111 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0022658 (UMLS CUI [3,1])
C0205082 (UMLS CUI [3,2])
Cancer Other | Primary tumor site Different Liver carcinoma | Histology Different Liver carcinoma
Item
previous or concurrent cancer that is distinct in primary site or histology from hcc
boolean
C1707251 (UMLS CUI [1])
C0475447 (UMLS CUI [2,1])
C1705242 (UMLS CUI [2,2])
C2239176 (UMLS CUI [2,3])
C4048239 (UMLS CUI [3,1])
C1705242 (UMLS CUI [3,2])
C2239176 (UMLS CUI [3,3])
Pregnancy | Breast Feeding
Item
pregnant women or lactating women;
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Fluorouracil allergy | Hypersensitivity Oxaliplatin | Hypersensitivity Leucovorin Calcium | Iodine contrast allergy
Item
allergy to fluorouracil, oxaliplatin, leucovorin calcium or iodine contrast agent.
boolean
C0570698 (UMLS CUI [1])
C0020517 (UMLS CUI [2,1])
C0069717 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C0731033 (UMLS CUI [3,2])
C4022917 (UMLS CUI [4])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial